Investigational Medication for Alpha-1 Patients

Trial Objective

Investigational Medication for Alpha-1 PatientsResearchers want to study the safety, tolerability and effectiveness of an investigational medicine for use in people with alpha-1 antitrypsin deficiency (AATD). Those interested in participating must have a PiZZ genotype. Participants may be able to complete some of the study visits at home with a home health nurse.


Active Clinical Trials Currently Recruiting

Who Can Participate

Anyone between the ages of 18-80 who are confirmed to have a PiZZ genotype.

Age: 18-80    Gender: Any Gender

Estimated Time Commitment

13-18 weeks

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Available

Trial Contact

For more information, contact:

Kris Eliopoulous

Kristina Eliopoulos

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Vertex Pharmaceuticals, Inc.


Request More Information

Complete this form to learn more about this study and see if you qualify.